UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program
UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program
批准号:
10195476
负责人:
PRIMO N. LARA
金额:
$73.61万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-08-01 至 2026-07-31
关键词:
Automobile DrivingBasic ScienceCancer PatientCenter for Translational Science ActivitiesClinicalClinical Oncology Supplement (K12)Clinical ResearchClinical SkillsClinical TrialsCommunicationCompetenceComprehensive Cancer CenterCustomDevelopmentDisciplineEnsureEnvironmentEthicsEvaluationFacultyFarGoFundingGoalsGrantInfrastructureLanguageMalignant NeoplasmsMentorsMentorshipNCI Scholars ProgramOncologyPatientsPhysiciansProgram DevelopmentResearchResearch DesignResearch PersonnelResearch Project GrantsResearch TrainingSECTM1 geneScienceScientistTimeTrainingTranslational ResearchVisionWritingbasecancer clinical trialcareercareer developmentclinical investigationdidactic educationdrug developmentdrug discoveryevidence baseimproved outcomeinnovationinterestmedical schoolsmultidisciplinarypatient orientedpatient oriented researchprogramsresearch and developmentskillssuccesstranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The overarching goal of the UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development
Program (CDP) is to nurture clinician or basic/translational junior faculty to become independent, patient-
oriented cancer researchers who are highly trained in translational, team-driven research. Using 1) core
competencies, 2) advanced oncology coursework, 3) career development, 4) mentored research, and 5) cross-
discipline exposure, the CDP provides two new scholars per year (six at any one time) a three-year career
development program aimed at honing ideas and skills that go far beyond their initial disciplinary boundaries.
Scholars will overcome language and cultural barriers that typically exist between clinical and
basic/translational researchers, take advantage of the collaborative research environment at UC Davis,
participate in multidisciplinary and translational forums, and gather essential skills in research design, clinical
trial development, team science, grant writing, ethical conduct of research, communication, and career
development. The vision is to enhance translational research by training physician-scientists to incorporate and
utilize basic/correlative science in their pursuit of clinical trials ("Clinical Track"), and conversely, driving basic
scientists towards patient-driven drug development and clinical research ("Basic/Translational Track"). To
maintain the emphasis on patient-driven clinical research, CDP scholars, under the mentorship of both a
clinical mentor and basic/translational mentor, will be required to develop and initiate/conduct their own
investigator-initiated clinical trial during the training period. The program will leverage the outstanding research,
training, and evaluation expertise and infrastructure of the NCI-designated UC Davis Comprehensive Cancer
Center, NCATS-funded Clinical and Translational Research Center (CTSC), and School of Medicine Career
Development Program. It will be overseen and enhanced by a highly organized internal Oversight Committee
and external Advisory Board. Overall, the CDP seeks to accomplish the following specific aims: 1) Offer a
competency-based didactic curriculum to promote team science, encourage translational research, and hone
essential skills for clinical trial development and career/research success; 2) Oversee individualized patient-
oriented research projects customized to the interests and needs of each scholar; and 3) Provide oversight of
scholar training to ensure the progressive development of fully competent interdisciplinary researchers who
can successfully conduct cancer clinical trials. These specific aims will build a critical mass of trained scientists
at the forefront of innovative, impactful, evidence-based research, who can oversee projects encompassing the
entire continuum of research from basic science (target identification and drug discovery) through translational
science (drug development and correlative science) to clinical investigation. By doing so, we offer the potential
of enhancing the success of clinician scientists and improving outcomes for cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase I Molecular and Clinical Pharmacodynamic Trials ETCTN
-
批准号:9095678
-
项目类别:
-
资助金额:$87.11万
-
财政年份:2014
-
负责人:PRIMO N. LARA
-
依托单位:
A Correlative Biomarker Analysis for A Phase I Trial of the Combination of Lenalidomide and Blinatumomab in Patients with Relapsed or Refractory NHL
-
批准号:10192396
-
项目类别:
-
资助金额:$20.74万
-
财政年份:2014
-
负责人:PRIMO N. LARA
-
依托单位:
UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program
-
批准号:10681247
-
项目类别:
-
资助金额:$73.47万
-
财政年份:2011
-
负责人:PRIMO N. LARA
-
依托单位:
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
-
批准号:8302192
-
项目类别:
-
资助金额:$40.92万
-
财政年份:2011
-
负责人:PRIMO N. LARA
-
依托单位:
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
-
批准号:8918454
-
项目类别:
-
资助金额:$112.99万
-
财政年份:2011
-
负责人:PRIMO N. LARA
-
依托单位:
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
-
批准号:8090131
-
项目类别:
-
资助金额:$11.87万
-
财政年份:2011
-
负责人:PRIMO N. LARA
-
依托单位:
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
-
批准号:9336795
-
项目类别:
-
资助金额:$80.36万
-
财政年份:2011
-
负责人:PRIMO N. LARA
-
依托单位:
UC Davis Paul Calabresi K12 Clinical Oncology Research Career Development Program
-
批准号:10429982
-
项目类别:
-
资助金额:$66.94万
-
财政年份:2011
-
负责人:PRIMO N. LARA
-
依托单位:
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
-
批准号:8518259
-
项目类别:
-
资助金额:$76.8万
-
财政年份:2011
-
负责人:PRIMO N. LARA
-
依托单位:
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
-
批准号:10018465
-
项目类别:
-
资助金额:$79.67万
-
财政年份:2009
-
负责人:PRIMO N. LARA
-
依托单位:
Paul Calabresi Career Development Award for Clinical Oncology (K12) at UC Davis
-
批准号:9753121
-
项目类别:
-
资助金额:$91.32万
-
财政年份:2009
-
负责人:PRIMO N. LARA
-
依托单位:
Biochemical markers of bone turnover in metastatic prostate cancer
-
批准号:7080230
-
项目类别:
-
资助金额:$12.89万
-
财政年份:2006
-
负责人:PRIMO N. LARA
-
依托单位:
Biochemical markers of bone turnover in metastatic prostate cancer
-
批准号:7841768
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2006
-
负责人:PRIMO N. LARA
-
依托单位:
Biochemical markers of bone turnover in metastatic prostate cancer
-
批准号:7278803
-
项目类别:
-
资助金额:$8.48万
-
财政年份:2006
-
负责人:PRIMO N. LARA
-
依托单位:
Biochemical markers of bone turnover in metastatic prostate cancer
-
批准号:7626284
-
项目类别:
-
资助金额:$27.47万
-
财政年份:2006
-
负责人:PRIMO N. LARA
-
依托单位:
Biochemical markers of bone turnover in metastatic prostate cancer
-
批准号:7477292
-
项目类别:
-
资助金额:$26.99万
-
财政年份:2006
-
负责人:PRIMO N. LARA
-
依托单位:
Barriers to accrual in cancer clinical trials
-
批准号:6789313
-
项目类别:
-
资助金额:$61.42万
-
财政年份:2003
-
负责人:PRIMO N. LARA
-
依托单位:
Barriers to accrual in cancer clinical trials
-
批准号:6666026
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2003
-
负责人:PRIMO N. LARA
-
依托单位:
Barriers to accrual in cancer clinical trials
-
批准号:6880796
-
项目类别:
-
资助金额:$9.52万
-
财政年份:2003
-
负责人:PRIMO N. LARA
-
依托单位:
Cancer Center Support Grant P30
-
批准号:10245597
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2002
-
负责人:PRIMO N. LARA
-
依托单位:
海外基金